A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors

Human Pathology

Volumn 32, Issue 2, 2001, Pages 156-162

  Bruch, Leslie A ^a   Hill, D Ashley ^a   Cai, Dan X ^a   Levy, Beth K ^a   Dehner, L P ^a   Perry, Arie ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical teratoid rhabdoid tumor; Central nervous system; Chromosome 22; In situ hybridization; Medulloblastoma; Pediatric

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 22Q; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; PROGNOSIS; RHABDOID TUMOR; TERATOMA;

EID: 0035120610     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.21572     Document Type: Article

References (15)

1. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity
2. Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. A Pediatric Oncology Group Study
3. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood
4. Atypical teratoid/rhabdoid tumor of the central nervous system: An aggressive pediatric brain tumor
5. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system
6. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors
7. Narrowing the critical region for a rhabdoid tumor locus in 22q11
8. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors
9. Chromosome 22 deletion analysis and mutation screening of INI1 in infants with medulloblastoma-primitive neuroectodermal tumor
10. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
11. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors
12. Medulloblastoma
13. Atypical teratoid/rhabdoid tumor
14. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotypephenotype correlations
15. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers